Incidence and Risk Factors of Intrauterine Transmission Among Pregnant Women With Chronic Hepatitis B Virus Infection

Goals: To identify the potential risk factors of hepatitis B virus (HBV) intrauterine transmission and predict the incidence of HBV intrauterine transmission among hepatitis B surface antigen–positive pregnant women with diverse viral load. Background: The intrauterine transmission of HBV significantly contributes to the persistence of a high number of patients infected with HBV. However, its risk factors remain unclear. Materials and Methods: A prospective study was performed on hepatitis B surface antigen–positive pregnant women who delivered from June 2012 to December 2016 at Wuhan Medical Care Center for Women and Children, Wuhan, China. Results: In total, 1200 women paired with 1219 infants were enrolled. In total, 11 (0.9%) infants were identified with intrauterine transmission. We observed that all infants with intrauterine transmission were born to hepatitis B e antigen–positive mothers who had serum HBV DNA levels >7 log10 copies/mL. Our study suggested that the HBV DNA levels (for each log10 copies/mL increase, odds ratio=5.43; 95% confidence interval, 1.31-22.43; P=0.019) had independent effects on HBV intrauterine transmission in a multivariate logistic regression model. Moreover, cesarean section (odds ratio=0.18; 95% confidence interval, 0.04-0.74; P=0.018) was associated with a reduced risk of HBV intrauterine transmission. The predictive rates of intrauterine transmission were 0.06%, 0.50%, 2.81%, 8.89% in infants with maternal HBV DNA levels of 105, 106, 107, 108 copies/mL, respectively. Conclusions: Our data confirmed that increasing maternal viral load has the ability to predict intrauterine HBV transmission. Vaginal delivery increased risk of HBV transmission in infants compared with cesarean section. Further studies are warranted to clarify the possible mechanism underlying these associations.

[1]  Q. Cao,et al.  Serological positive markers of hepatitis B virus in femoral venous blood or umbilical cord blood should not be evidence of in-utero infection among neonates , 2016, BMC Infectious Diseases.

[2]  Bin Zhang,et al.  Genetic variant in CXCL13 gene is associated with susceptibility to intrauterine infection of hepatitis B virus , 2016, Scientific Reports.

[3]  O. Akbari,et al.  Maternal-Derived Hepatitis B Virus e Antigen Alters Macrophage Function in Offspring to Drive Viral Persistence after Vertical Transmission. , 2016, Immunity.

[4]  K. Owusu-Edusei,et al.  Cost‐effectiveness of active‐passive prophylaxis and antiviral prophylaxis during pregnancy to prevent perinatal hepatitis B virus infection , 2016, Hepatology.

[5]  Yukai Du,et al.  Controversy and Strategies Exploration in Blocking Mother-to-Child Transmission of Hepatitis B , 2016, International reviews of immunology.

[6]  Jue Liu,et al.  Seroepidemiology of hepatitis B virus infection in 2 million men aged 21-49 years in rural China: a population-based, cross-sectional study. , 2016, The Lancet. Infectious diseases.

[7]  Gérard Krause,et al.  Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013 , 2015, The Lancet.

[8]  Noele P. Nelson,et al.  Outcomes of Infants Born to Women Infected With Hepatitis B , 2015, Pediatrics.

[9]  M. Buti,et al.  Hepatitis B e Antigen Status and Hepatitis B DNA Levels in Women of Childbearing Age with Chronic Hepatitis B Infection Screening for Clinical Trials , 2015, PloS one.

[10]  P. Li,et al.  Peripheral Blood Mononuclear Cell Traffic Plays a Crucial Role in Mother-to-Infant Transmission of Hepatitis B Virus , 2015, International journal of biological sciences.

[11]  Hong Tang,et al.  Factors associated with mother-to-child transmission of hepatitis B virus despite immunoprophylaxis. , 2015, Internal medicine.

[12]  F. Zhang,et al.  Evaluation of neonatal Toll-like receptors 3 (c.1377C/T) and 9 (G2848A) gene polymorphisms in HBV intrauterine transmission susceptibility , 2014, Epidemiology and Infection.

[13]  Shuyu Zhao,et al.  Analysis on the outcomes of hepatitis B virus perinatal vertical transmission: nested case–control study , 2014, European journal of gastroenterology & hepatology.

[14]  E. Petersen,et al.  Maternal transmission risk and antibody levels against hepatitis B virus e antigen in pregnant women. , 2014, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[15]  Hua Zhang,et al.  Telbivudine or lamivudine use in late pregnancy safely reduces perinatal transmission of hepatitis B virus in real-life practice , 2014, Hepatology.

[16]  Xiaomin Xiao,et al.  Risk factors for intrauterine infection with hepatitis B virus , 2014, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[17]  X. Liang,et al.  Dynamic changes of HBV markers and HBV DNA load in infants born to HBsAg(+) mothers: can positivity of HBsAg or HBV DNA at birth be an indicator for HBV infection of infants? , 2013, BMC Infectious Diseases.

[18]  Z. Duan,et al.  Cesarean section reduces perinatal transmission of hepatitis B virus infection from hepatitis B surface antigen-positive women to their infants. , 2013, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[19]  M. Buti,et al.  The State of Hepatitis B and C in the Mediterranean and Balkan Countries: Report from a Summit Conference , 2013, Journal of viral hepatitis.

[20]  H. Hsu,et al.  Mother-to-infant transmission of hepatitis B virus infection: significance of maternal viral load and strategies for intervention. , 2013, Journal of hepatology.

[21]  Maggie Westby,et al.  Diagnosis and management of chronic hepatitis B in children, young people, and adults: summary of NICE guidance , 2013, BMJ.

[22]  Qingliang Shao,et al.  Role of peripheral blood mononuclear cell transportation from mother to baby in HBV intrauterine infection , 2013, Archives of Gynecology and Obstetrics.

[23]  L. Feng,et al.  Risk factors of HBV intrauterine transmission among HBsAg‐positive pregnant women , 2013, Journal of viral hepatitis.

[24]  Q. Qian,et al.  Role of maternal viremia and placental infection in hepatitis B virus intrauterine transmission. , 2013, Microbes and infection.

[25]  Xiaofeng Liang,et al.  An algorithm for risk assessment and intervention of mother to child transmission of hepatitis B virus. , 2012, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[26]  EASL clinical practice guidelines: Management of chronic hepatitis B virus infection. , 2012, Journal of hepatology.

[27]  Wei Zhao,et al.  A prospective and open-label study for the efficacy and safety of telbivudine in pregnancy for the prevention of perinatal transmission of hepatitis B virus infection. , 2011, Journal of hepatology.

[28]  P. Revill,et al.  The hepatitis B e antigen suppresses IL‐1β‐mediated NF‐κB activation in hepatocytes , 2011, Journal of viral hepatitis.

[29]  S. Locarnini,et al.  The hepatitis B e antigen (HBeAg) targets and suppresses activation of the toll-like receptor signaling pathway. , 2011, Journal of hepatology.

[30]  J. Preiksaitis,et al.  Factors associated with vaccine failure and vertical transmission of hepatitis B among a cohort of Canadian mothers and infants , 2011, Journal of viral hepatitis.

[31]  S. Locarnini,et al.  Perinatal transmission of hepatitis B virus: an Australian experience , 2009, The Medical journal of Australia.

[32]  Ding‐Shinn Chen Hepatitis B vaccination: The key towards elimination and eradication of hepatitis B. , 2009, Journal of hepatology.

[33]  Zhi-ying Zhang,et al.  Maternal hepatitis B virus (HBV) DNA positivity and sexual intercourse are associated with HBV intrauterine transmission in China: A prospective case–control study , 2007, Journal of gastroenterology and hepatology.

[34]  J. Brok,et al.  Effect of hepatitis B immunisation in newborn infants of mothers positive for hepatitis B surface antigen: systematic review and meta-analysis , 2006, BMJ : British Medical Journal.

[35]  De-zhong Xu,et al.  Heterogeneity analysis of the hepatitis B virus genome in intrauterine infection , 2005, Journal of medical virology.

[36]  Lei Shi,et al.  Mechanism of intrauterine infection of hepatitis B virus. , 2004, World journal of gastroenterology.

[37]  L. Zou,et al.  Interruption of HBV intrauterine transmission: a clinical study. , 2003, World journal of gastroenterology.

[38]  Bernard C. K. Choi,et al.  Risk factors and mechanism of transplacental transmission of hepatitis B virus: A case‐control study , 2002, Journal of medical virology.

[39]  B. McMahon,et al.  Seroprevalence of hepatitis B viral markers in 52,000 Alaska Natives. , 1993, American journal of epidemiology.